Alnylam Pharmaceuticals (ALNY) Share-based Compensation (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.06% |
| Dec 31, 2025 | -33.80% |
| Sep 30, 2025 | -3.11% |
| Jun 30, 2025 | 96.92% |
| Mar 31, 2025 | -38.12% |
| Dec 31, 2024 | 100.08% |
| Sep 30, 2024 | -48.70% |
| Jun 30, 2024 | 96.90% |
| Mar 31, 2024 | 7.98% |
| Dec 31, 2023 | -34.32% |
| Sep 30, 2023 | -15.65% |
| Jun 30, 2023 | 89.76% |
| Mar 31, 2023 | -6.59% |
| Dec 31, 2022 | -66.62% |
| Sep 30, 2022 | 320.46% |
| Jun 30, 2022 | 4.02% |
| Mar 31, 2022 | -34.29% |
| Dec 31, 2021 | 33.61% |
| Sep 30, 2021 | 4.02% |
| Jun 30, 2021 | -42.40% |
| Mar 31, 2021 | 62.48% |
| Dec 31, 2020 | -8.02% |
| Sep 30, 2020 | 10.40% |
| Jun 30, 2020 | -2.38% |
| Mar 31, 2020 | -47.77% |
| Dec 31, 2019 | 43.88% |
| Sep 30, 2019 | 50.34% |
| Jun 30, 2019 | -4.46% |
| Mar 31, 2019 | 14.51% |
| Dec 31, 2018 | -38.90% |
| Sep 30, 2018 | 105.85% |
| Jun 30, 2018 | 13.57% |
| Sep 30, 2017 | -18.02% |
| Jun 30, 2017 | -15.67% |
| Mar 31, 2017 | -23.89% |
| Dec 31, 2016 | 121.08% |
| Sep 30, 2016 | 0.69% |
| Jun 30, 2016 | -60.49% |
| Mar 31, 2016 | 51.29% |
| Dec 31, 2015 | 181.47% |
| Sep 30, 2015 | 36.82% |
| Jun 30, 2015 | -51.07% |
| Mar 31, 2015 | -38.71% |
| Dec 31, 2014 | 422.68% |
| Sep 30, 2014 | 0.55% |
| Jun 30, 2014 | -54.27% |
| Mar 31, 2014 | 3.42% |
| Dec 31, 2013 | -20.56% |
| Sep 30, 2013 | 209.32% |
| Jun 30, 2013 | -28.46% |
| Mar 31, 2013 | 12.97% |
| Dec 31, 2012 | -19.61% |
| Sep 30, 2012 | 9.37% |
| Jun 30, 2012 | -1.90% |
| Mar 31, 2012 | -22.68% |
| Dec 31, 2011 | -4.13% |
| Sep 30, 2011 | 1.04% |
| Jun 30, 2011 | 2.23% |
| Mar 31, 2011 | -8.28% |
| Dec 31, 2010 | -0.38% |
| Sep 30, 2010 | -10.99% |
| Jun 30, 2010 | -4.86% |
| Mar 31, 2010 | 35.20% |
| Dec 31, 2009 | -30.07% |